Skip to content
Menu

Uranium Royalty Corp. UROY

Full chart Compare
Set alert

Price alert · UROY

All alert types
2.32 USD -0.22 (-8.66%)

Regular-session close

2.34 +0.02 +0.86%

After hours · Nov 20, 4:00 PM ET

2.30 Day range 2.53
2.30 52-week range 5.52
YTD
-34.46%
1 year
-30.12%

Fundamental scorecard

12 of 25 checks passed on UROY’s reported financials

ValueGrowthProfitabilityHealthDividend

12of 25 checks passed

  • Value 4 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 2 of 5
  • Dividend No data

Statements to Jul 31, 2026.

Value 4 of 5

  • No data:P/E below its own 5-year median P/E 15.9. Not enough data to decide.
  • Passed:P/E under 20 P/E 15.9: an earnings yield of 6.3%.
  • Passed:Price to sales below its own 5-year median Price to sales 4.1 against a 5-year median of 14.3.
  • Passed:Price to book below its own 5-year median Price to book 0.9 against a 5-year median of 1.6.
  • Passed:Free cash flow yield above 4% Free cash flow of 210M is 23.7% of the market value.

Growth 3 of 5

  • Passed:Revenue grew over the last year Revenue of 215M is +505.8% on the 12 months before.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Passed:Earnings per share grew over the last year EPS 0.38 against -0.01 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -0.01 in FY 2021, 0.29 in FY 2026.
  • Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -97.4% on the last 12 months.

Profitability 3 of 5

  • Passed:Profitable over the last year Net income of 55.4M over the last 12 months.
  • Failed:Profitable in each of the last five fiscal years A profit in 2 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of 9.5%.
  • Passed:Net margin above its 5-year average Net margin of 25.7% against a 5-year average of -4.2%.
  • Passed:Free cash flow is at least 80% of net income Free cash flow of 210M is 378.0% of net income.

Financial health 2 of 5

  • Failed:Short-term assets cover short-term liabilities Short-term assets of 121M against short-term liabilities of 138M.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 121M against long-term liabilities of 681M.
  • Failed:Net debt under 40% of equity Net debt of 478M is 49.7% of equity.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 210M is 35.3% of debt.
  • Passed:Operating profit covers interest at least 3 times Operating profit is 155 times the interest expense.

Dividend No data

  • No data:Pays a dividend Not enough data to decide.
  • No data:Yield above 1.5% Not enough data to decide.
  • No data:Pays out under 75% of profit Not enough data to decide.
  • No data:Covered by free cash flow Not enough data to decide.
  • No data:Not cut in the last five fiscal years Not enough data to decide.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What UROY owns and owes, as of Jul 31, 2026

Short term and long term

Balance sheet · 1.91B of assets

Debt, equity and cash by year

Now: 294M more cash than debt

Fiscal years. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

0.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 3
  • P/B 5

Valuation

P/E 13.6×
P/S 2.9×
P/B 1.7×
P/FCF 4.1×
EV/EBITDA 5.0×
EV/Sales 1.4×
FCF Yield 24.1%

Profitability

Gross Margin 30.6%
Operating Margin 27.1%
Net Margin 21.5%
ROE 13.0%
ROIC 11.9%
ROA 10.9%

Growth (YoY)

Revenue 1553.7%
Operating Income 1553.7%
EPS (diluted) 974.4%
Free Cash Flow 649.7%

Financial Health

Current Ratio 5.9×
Quick Ratio 5.3×
Debt / Equity 0.0×
Net Debt / EBITDA -5.5×
Interest Coverage 0.0×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2026-04-30